Western blot analysis revealed that YBX1 knockdown decreased the protein expression of E2F1 in ovarian cancer cells, and half-life assays showed that YBX1 increased the stability of E2F1 mRNA (Fig. 4i, j; Supplementary Fig. 5h, i). The gene discussed is E2F1; the disease is ovarian cancer.